Commonwealth Equity Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
13,287
-5,339
| -29% | -$470K | ﹤0.01% | 2436 |
|
|
2025
Q1 | $1.7M | Buy |
18,626
+660
| +4% | +$60.1K | ﹤0.01% | 2041 |
|
|
2024
Q4 | $1.55M | Buy |
17,966
+631
| +4% | +$54.4K | ﹤0.01% | 2049 |
|
|
2024
Q3 | $1.65M | Sell |
17,335
-1,691
| -9% | -$161K | ﹤0.01% | 1946 |
|
|
2024
Q2 | $1.74M | Sell |
19,026
-2,263
| -11% | -$207K | ﹤0.01% | 1882 |
|
|
2024
Q1 | $1.93M | Buy |
21,289
+6,655
| +45% | +$604K | ﹤0.01% | 1814 |
|
|
2023
Q4 | $1.19M | Sell |
14,634
-4,317
| -23% | -$351K | ﹤0.01% | 2050 |
|
|
2023
Q3 | $1.51M | Buy |
18,951
+422
| +2% | +$33.7K | ﹤0.01% | 1796 |
|
|
2023
Q2 | $1.46M | Sell |
18,529
-314
| -2% | -$24.7K | ﹤0.01% | 1836 |
|
|
2023
Q1 | $1.46K | Sell |
18,843
-1,894
| -9% | -$147 | ﹤0.01% | 1767 |
|
|
2022
Q4 | $1.61M | Buy |
20,737
+4,688
| +29% | +$364K | ﹤0.01% | 1641 |
|
|
2022
Q3 | $1.08M | Sell |
16,049
-307
| -2% | -$20.6K | ﹤0.01% | 1841 |
|
|
2022
Q2 | $1.26M | Buy |
16,356
+683
| +4% | +$52.4K | ﹤0.01% | 1716 |
|
|
2022
Q1 | $1.25M | Sell |
15,673
-2,629
| -14% | -$210K | ﹤0.01% | 1825 |
|
|
2021
Q4 | $1.41M | Buy |
18,302
+1,815
| +11% | +$140K | ﹤0.01% | 1735 |
|
|
2021
Q3 | $1.2M | Buy |
16,487
+402
| +2% | +$29.3K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $1.18M | Sell |
16,085
-732
| -4% | -$53.5K | ﹤0.01% | 1799 |
|
|
2021
Q1 | $1.16M | Buy |
16,817
+2,367
| +16% | +$163K | ﹤0.01% | 1693 |
|
|
2020
Q4 | $960K | Buy |
14,450
+1,760
| +14% | +$117K | ﹤0.01% | 1678 |
|
|
2020
Q3 | $788K | Buy |
12,690
+1,572
| +14% | +$97.6K | ﹤0.01% | 1643 |
|
|
2020
Q2 | $692K | Buy |
+11,118
| New | +$692K | ﹤0.01% | 1654 |
|